Skip to content

Drug interactions

Lenacapavir + Losartan

Severity: Minor

Lenacapavir and Losartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor, which may increase exposure to CYP3A4 substrates, including losartan parent drug. Since losartan is also activated by CYP2C9 and the effect on the active metabolite is uncertain, clinical impact is likely small.

What this interaction means in plain words

Lenacapavir and Losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lenacapavir belongs to Anti Virals; Losartan belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by lenacapavir reducing losartan metabolism.

What to do

Monitor blood pressure and adverse effects such as hypotension or hyperkalemia when starting lenacapavir.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Losartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Losartan?

MediHelp rates the interaction as minor. Lenacapavir and Losartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lenacapavir is a moderate CYP3A inhibitor, which may increase exposure to CYP3A4 substrates, including losartan parent drug. Since losartan is also activated by CYP2C9 and the effect on the active metabolite is uncertain, clinical impact is likely small.

How serious is the interaction between Lenacapavir and Losartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and adverse effects such as hypotension or hyperkalemia when starting lenacapavir.

What other medicines interact with Losartan?

MediHelp also lists interactions of Losartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Losartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in